SCHEMBL7746645

SCHEMBL7746645

CCCCC(=O)Nc1oc(-c2ccc(-c3cccc([N+](=O)[O-])c3)cc2O)nc1C1=CC(=S)CC=C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPN P05981 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 5/20 0.36
HPGD P15428 5/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
GAA P10253 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
ALOX12 P18054 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MAPK1 P28482 2/20 0.35
MAPT P10636 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HDAC1 Q13547 3/20 0.35
HDAC2 Q92769 3/20 0.35
HDAC8 Q9BY41 2/20 0.35
HDAC3 O15379 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744069 0.90 KDR (0.40) ALDH1A1HPGDSMN1; SMN2GAACYP1A2
SCHEMBL7739072 0.89 KDR (0.43) HPNSMN1; SMN2KDM4EMAPT
SCHEMBL7739003 0.85 HPN (0.44) HPNMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7744773 0.85 HPN (0.41) HPNMEN1KMT2AALDH1A1HPGD
SCHEMBL7744081 0.85 FLT1 (0.46) HPNMEN1KMT2AALDH1A1HPGD
SCHEMBL7744096 0.83 MEN1 (0.42) HPNMEN1KMT2AALDH1A1HPGD
SCHEMBL7744054 0.83 MEN1 (0.42) HPNMEN1KMT2AALDH1A1HPGD
SCHEMBL7739075 0.82 KDR (0.42) HPNMEN1KMT2AALDH1A1HPGD
SCHEMBL7744672 0.81 HPN (0.42) HPNMEN1KMT2AALDH1A1HPGD
SCHEMBL7744758 0.81 ALDH1A1 (0.46) HPNMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed